[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ITMI20031941A1 - Composizioni farmaceutiche topiche per il trattamento delle dermatiti - Google Patents

Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Info

Publication number
ITMI20031941A1
ITMI20031941A1 IT001941A ITMI20031941A ITMI20031941A1 IT MI20031941 A1 ITMI20031941 A1 IT MI20031941A1 IT 001941 A IT001941 A IT 001941A IT MI20031941 A ITMI20031941 A IT MI20031941A IT MI20031941 A1 ITMI20031941 A1 IT MI20031941A1
Authority
IT
Italy
Prior art keywords
dermatitis
pharmaceutical compositions
topical pharmaceutical
dermatitis treatment
telmesteine
Prior art date
Application number
IT001941A
Other languages
English (en)
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Priority to IT001941A priority Critical patent/ITMI20031941A1/it
Priority to PCT/EP2004/011228 priority patent/WO2005037275A1/en
Priority to CA002540859A priority patent/CA2540859A1/en
Priority to EP04790183A priority patent/EP1670464B1/en
Priority to DE602004031964T priority patent/DE602004031964D1/de
Priority to BRPI0415225-5A priority patent/BRPI0415225A/pt
Priority to CNA2004800290615A priority patent/CN1863529A/zh
Priority to JP2006530119A priority patent/JP2007508264A/ja
Priority to US10/575,023 priority patent/US20070213381A1/en
Priority to AT04790183T priority patent/ATE502636T1/de
Priority to AU2004281521A priority patent/AU2004281521B2/en
Publication of ITMI20031941A1 publication Critical patent/ITMI20031941A1/it
Priority to AU2008203101A priority patent/AU2008203101A1/en
Priority to US12/575,848 priority patent/US8431601B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IT001941A 2003-10-09 2003-10-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti ITMI20031941A1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT001941A ITMI20031941A1 (it) 2003-10-09 2003-10-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti
BRPI0415225-5A BRPI0415225A (pt) 2003-10-09 2004-10-07 composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos
CA002540859A CA2540859A1 (en) 2003-10-09 2004-10-07 Topical compositions comprising telmesteine for treating dermatological disorders
EP04790183A EP1670464B1 (en) 2003-10-09 2004-10-07 Topical compositions comprising telmesteine for treating dermatological disorders
DE602004031964T DE602004031964D1 (de) 2003-10-09 2004-10-07 Ndlung von dermatologischen erkrankungen
PCT/EP2004/011228 WO2005037275A1 (en) 2003-10-09 2004-10-07 Topical compositions comprising telmesteine for treating dermatological disorders
CNA2004800290615A CN1863529A (zh) 2003-10-09 2004-10-07 用于治疗皮肤病症的包括替美斯丁的局部组合物
JP2006530119A JP2007508264A (ja) 2003-10-09 2004-10-07 テルメステインを含む皮膚疾患治療用局所組成物
US10/575,023 US20070213381A1 (en) 2003-10-09 2004-10-07 Topical Compositions Comprising Telmesteine for Treating Dermatological Disorders
AT04790183T ATE502636T1 (de) 2003-10-09 2004-10-07 Topische zusammensetzungen mit telmestein zur behandlung von dermatologischen erkrankungen
AU2004281521A AU2004281521B2 (en) 2003-10-09 2004-10-07 Topical compositions comprising telmesteine for treating dermatological disorders
AU2008203101A AU2008203101A1 (en) 2003-10-09 2008-07-14 Topical compositions comprising telmesteine for treating dermatological disorders
US12/575,848 US8431601B2 (en) 2003-10-09 2009-10-08 Topical compositions comprising telmesteine for treating dermatological disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001941A ITMI20031941A1 (it) 2003-10-09 2003-10-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Publications (1)

Publication Number Publication Date
ITMI20031941A1 true ITMI20031941A1 (it) 2005-04-10

Family

ID=34452248

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001941A ITMI20031941A1 (it) 2003-10-09 2003-10-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Country Status (11)

Country Link
US (2) US20070213381A1 (it)
EP (1) EP1670464B1 (it)
JP (1) JP2007508264A (it)
CN (1) CN1863529A (it)
AT (1) ATE502636T1 (it)
AU (2) AU2004281521B2 (it)
BR (1) BRPI0415225A (it)
CA (1) CA2540859A1 (it)
DE (1) DE602004031964D1 (it)
IT (1) ITMI20031941A1 (it)
WO (1) WO2005037275A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471135A (en) * 2009-06-19 2010-12-22 H D S Ltd Hair dye composition and use in reducing contact allergy
BR112012000254A2 (pt) * 2009-07-08 2016-02-16 Dermira Canada Inc análogos de tofa úteis no tratamento de distúrbios ou condições dermatológicas.
US20120109042A1 (en) * 2010-10-28 2012-05-03 John Koo Methods of Treating Diseased Tissue
KR101670765B1 (ko) * 2014-09-19 2016-11-01 주식회사 명진뉴텍 글리신계 물질을 포함하는 방부조성물
ES2834905T3 (es) 2017-06-27 2021-06-21 Daxxin AB Composición líquida para lavar el cuero cabelludo y el cabello, o para lavar la piel que comprende piroctona olamina
US11529299B2 (en) 2017-06-30 2022-12-20 The Procter & Gamble Company Hair care compositions comprising a 2-pyridinol-n-oxide material and an iron chelator
CA3066177C (en) 2017-06-30 2023-06-06 The Procter & Gamble Company Deodorant and antiperspirant compositions
US10543164B2 (en) 2017-06-30 2020-01-28 The Procter & Gamble Company Deodorant compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE74354T1 (de) 1988-06-29 1992-04-15 Yason Srl N-karbethoxy-4-thiazolin-karbonsaeure, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
CA2164955A1 (en) * 1993-06-18 1995-01-05 Richard J. Sharpe Method for treating hyperkeratosis and diseases mediated by proteases
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Also Published As

Publication number Publication date
EP1670464A1 (en) 2006-06-21
JP2007508264A (ja) 2007-04-05
US20070213381A1 (en) 2007-09-13
US20100130568A1 (en) 2010-05-27
BRPI0415225A (pt) 2006-12-05
AU2008203101A1 (en) 2008-08-07
CA2540859A1 (en) 2005-04-28
AU2004281521A1 (en) 2005-04-28
WO2005037275A1 (en) 2005-04-28
DE602004031964D1 (de) 2011-05-05
US8431601B2 (en) 2013-04-30
ATE502636T1 (de) 2011-04-15
EP1670464B1 (en) 2011-03-23
AU2004281521B2 (en) 2008-04-17
CN1863529A (zh) 2006-11-15

Similar Documents

Publication Publication Date Title
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
BRPI0307550B8 (pt) composição farmacêutica em gel tópica, de adapaleno 0,3%
ITMI20020756A1 (it) Composizioni farmaceutiche topiche per il trattamento delle dermatiti
SI2671882T1 (en) Pyrrolo (2,3-b) pyridin-4-yl-amines and pyrrolo (2 3-b) pyrimidin-4-yl-amines as inhibitors of janus kinase
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
NO20025263D0 (no) Topisk sammensetning for behandlingen av psoriasis og beslektede hud-lidelser
RU2013141845A (ru) Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа
WO2017182885A3 (en) Compositions for the treatment of hyperkeratosis disorders
AR065317A1 (es) Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales
DK1569896T3 (da) Tetrahydronaphthalenderivater
ATE442864T1 (de) Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff
WO2009150408A3 (en) Topical antimuscarinic formulations
ITMI20031941A1 (it) Composizioni farmaceutiche topiche per il trattamento delle dermatiti
BR112012030006A2 (pt) composições farmacêuticas tópicas
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
JP2016501236A5 (it)
WO2009036751A3 (de) Kosmetische oder dermatologische zusammensetzung zur topischen verwendung
WO2017205779A3 (en) Compositions and methods for treating disorders related to inflammasome activity and il-1alpha expression
WO2024173581A3 (en) Formulations for the treatment of skin diseases and conditions
IL197035A0 (en) Pharmaceutical formula for treating skin disease
DE102006010720A1 (de) Topisches Produkt zur Stimulation des Wachstums von Propionibakterien und seine Verwendung
WO2010000686A2 (en) Composition for topical use
BR0013552A (pt) Azatioprina tópica para o tratamento de doenças auto-imunes orais
DOP2003000728A (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenetivos